Arvia’s Nyex™ Treatment Systems provide a highly reliable and targeted treatment of API’s from wastewater ensuring the maintenance of legislative standards for discharge.
Our systems are modular in nature, which means they can be scaled to meet your flow rate requirements. This also means that it can be easily adapted to tackle new regulations, emerging contaminants and extension or seasonal alteration of production lines.
Our treatment experts have tried and tested the system as an emergency response on calamity wastewater and it is carefully designed for ease of transportation to where this application is required.
As pharmaceutical companies pride themselves on quality customer care, ensuring patients encounter minimal barriers to treatment is of utmost importance. Nyex™ treatment will play a major part in the sustainable delivery of your products and Arvia guarantee that your organisation can continue to develop and supply essential medicines without the concern for operational downtime due to water treatment failures.
Get in touch to discuss your company’s treatment challenges and arrange a treatability trial on your wastewater today.